EcoR1 Capital’s vTv Therapeutics VTVT Stock Holding History

EcoR1 Capital’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-20,858	Closed	-$830K	–	96
2021 Q4	$830K	Buy	+20,858	New	+$1.12M	0.03%	67

Other funds holding VTVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EcoR1 Capital's VTVT Position: Q1 2022 in Review

EcoR1 Capital sold out of vTv Therapeutics (VTVT) in Q1 2022, closing a stake of 20,858 shares — an estimated $830K sold.

EcoR1 Capital first reported a position in VTVT in Q4 2021 and held it in 1 quarter. The position peaked at $830K in Q4 2021. 24 funds tracked by Wall St. Rank hold VTVT as of Q1 2022.

EcoR1 Capital reported no remaining vTv Therapeutics position as of Q1 2022 after selling out during the quarter.
EcoR1 Capital sold 20,858 vTv Therapeutics shares in Q1 2022, an estimated $830K.
EcoR1 Capital first reported a position in vTv Therapeutics in Q4 2021 and held it in 1 quarter.
EcoR1 Capital's vTv Therapeutics position peaked at $830K in Q4 2021.
24 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2022.

Based on EcoR1 Capital's 13F filing for Q1 2022, filed 16 May 2022.